Artificial Intelligence
OpenAI launches Rosalind Academic Plan for university labs
OpenAI launched the Rosalind Academic Plan for research labs at US universities, offering up to 30 Business Standard seats for twelve months and limiting access to GPT-Rosalind and its Workbench.
- OpenAI launched the Rosalind Academic Plan for research labs at US universities.
- Eligible labs got up to 30 free seats on the Business Standard plan for up to twelve months.
- API access was not included in the offer.
- OpenAI said GPT-Rosalind was built for life sciences and that Rosalind Workbench linked it to tools for medicinal chemistry, genomics and lab experiments.
- OpenAI said it vetted the institution, the lead researcher and the planned use before approval, then monitored use afterwards.
OpenAI launched the Rosalind Academic Plan for research labs at US universities. It said approved labs could receive up to 30 seats on the Business Standard plan for up to twelve months, and that API access was excluded.
The company said the offer centred on GPT-Rosalind, a model it had built for life sciences. Through Rosalind Workbench, OpenAI said, the model connected to tools for medicinal chemistry, genomics and lab experiments.
OpenAI said it checked the institution, the lab’s lead researcher and the intended use before granting access. Once a lab was approved, the company said it monitored how the model was used.
For registered highly sensitive applications, OpenAI said its safeguards took the approved research context into account. The company also said it did not train on research data by default and would follow up when something was unclear.
Named in this story
Companies
- OpenAI
- launched the Rosalind Academic Plan and described its safeguards
Products and systems
- Rosalind Academic Plan
- the new free offering for qualifying university research labs
- Business Standard
- the plan on which eligible labs received seats
- GPT-Rosalind
- the model OpenAI said was built for life sciences
- Rosalind Workbench
- the interface that connected the model to specialist tools
How the source tells it
The piece read like a company announcement, with OpenAI’s claims about capability and safety repeated in a promotional register.
- vendor boosterism the company’s product and safety claims are repeated without independent challenge